Team
Oli Denne
Oli is an associate in our Cambridge office and is part of the Corporate Technology team.
Oli advises a range of companies in the tech and life sciences sectors on a variety of corporate matters, including venture capital investments, fundraisings, M&A and joint ventures.
CV ansehen
CV ausblenden
Karriere
| Since 2021 | Associate, Taylor Wessing |
| 2019 - 2020 | Associate, Slaughter and May |
| 2017 - 2019 | Trainee solicitor, Slaughter and May |
Ausbildung
| 2019 | Admitted as a solicitor in England & Wales |
| 2016 - 2017 | GDL & LPC, BPP Law School |
| 2012 - 2015 | BA Politics, University of Warwick |
Aktuelle News & Insights
Gesellschaftsrecht/ M&A & Kapitalmärkte
Klicken Sie hier für Details
Nuclera raises additional capital for eProtein™ desktop bioprinter to close Series B funding at $58 million
14. Juli 2022
von mehreren Autoren
Gesellschaftsrecht/ M&A & Kapitalmärkte
Klicken Sie hier für Details
Advising Placid0 on its acquisition by eyecare brand WALDO
25. Februar 2022
von mehreren Autoren
Life Sciences & Healthcare
Klicken Sie hier für Details
Advising Nuclera on its Series B funding round
2. Februar 2022
von mehreren Autoren
Gesellschaftsrecht/ M&A & Kapitalmärkte
Klicken Sie hier für Details
Advising Cambridge Epigenetix on its $88 million Series D funding round to advance best-in-class DNA sequencing technology platform
2. November 2021
von Ross McNaughton und Oli Denne
